
Tonix Pharmaceuticals Approved for Nasdaq Global Select Market Listing
Tonix Pharmaceuticals has received approval to transfer its stock listing to the Nasdaq Global Select Market, reflecting compliance with stricter requirements and potentially enhancing institutional visibility and liquidity as the company advances its CNS and immunology pipeline.
Read full story























